Virbac SA
Abierto
SectorSanidad
341 1.34
Resumen
Variación precio
24h
Mínimo
334
Máximo
341.5
Ingresos | -14M 68M |
|---|---|
Ventas | -12M 726M |
P/B Media del Sector | 18.906 50.958 |
Rentabilidad por dividendo | 0.44 |
Margen de beneficios | 9.427 |
Empleados | 6,442 |
EBITDA | -35M 121M |
Recomendaciones | Comprar |
|---|---|
Estimación a 12 Meses | +23.7% upside |
Rentabilidad por dividendo Media del Sector | 0.44% 2.41% |
|---|---|
Próximas Ganancias | 17 sept 2026 |
Capitalización Mercado | 52M 2.9B |
|---|---|
Apertura anterior | 339.66 |
Cierre anterior | 341 |
Noticias sobre sentimiento de mercado
By Acuity
18%
82%
35 / 342 Clasificación en Healthcare
Virbac SA Gráfico
Resultados pasados no son un indicador fiable de resultados futuros.
Acerca de Virbac SA
Virbac SA manufactures and sells a range of products and services for companion animals and farm animals in France, Europe, Latin America, North America, Asia, Pacific, and Africa and the Middle East. The company offers a range of vaccines, dental hygiene, reproduction, dermatology, parasiticides, diagnostic, antibiotics, and aquaculture products; and veterinary medicines for anesthesia, geriatrics, behavior, and injectable micronutrients, as well as petfood and electronic identification. It serves veterinarians, farmers, and pet owners. Virbac SA was founded in 1968 and is headquartered in Carros, France.
